VAERS reports by lot

Pfizer COVID-19 lot PAA156051: VAERS reports

97 VAERS reports list lot PAA156051 as a Pfizer COVID-19 vaccine, received between 2020-12-17 and 2024-02-27. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
97
Reports
9%
Marked serious
2
With a death outcome
15
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)7223%
Neurological4715%
Cardiac / Cardiovascular4213%
Gastrointestinal3912%
Dermatological (non-injection-site)248%
Injection-site / Local reaction248%
Allergic / Anaphylactic196%
Respiratory186%
Musculoskeletal165%
Thrombotic / Hematological62%
Psychiatric / Neuropsychiatric41%
Reproductive / Menstrual21%
Autoimmune / Immune-mediated10%

Where reports came from

U.S. state of the reporter, where given (top 12).

California22
Texas7
Ohio5
New York4
Illinois4
Florida4
Kentucky4
Oregon3
Missouri3
Idaho2
Louisiana2
Puerto Rico2

Reports by month received

2020-1210
2021-0135
2021-028
2021-0311
2021-048
2021-057
2021-065
2021-073
2021-082
2021-102
2021-122
2022-011
2022-071
2023-091
2024-021

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.